http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1976930-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f874eb11d4775decc4fd06a6071a4c9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-475 |
| filingDate | 2005-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b7a6b93688865f54b1765c6dd24a8df http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e24950019c874ad03d3f9f4f2516bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb00ad605643ac133535244d35aa3a6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63564e018f61580703f1dc49a7ad8cb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e263fb591cde238bd8d1f78ce32da5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98bf6b2e83b4b026df5bae70c85bc903 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_616b6233a9cd7055db9883ea6b7b52d8 |
| publicationDate | 2011-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-1976930-B |
| titleOfInvention | 6,7,8,9-substituted 1-phenyl-1,5-dihydro-pyrido(3,2-b)indol-2-ones useful as anti-infective pharmaceutical agents |
| abstract | This invention concerns the compounds (I); the N-oxides, salts, stereoisomeric forms, racemic mixtures, prodrugs, esters and metabolites thereof, wherein X is NR<2>, O, S, SO, SO2; R<1> is hydrogen, cyano, halo, substituted carbonyl, methanimidamidyl, N-hydroxy-methanimidamidyl, mono- or di(C1-4alkyl)methanimidamidyl, Het1 or Het2; n is 1, 2 or 3; R<2> is hydrogen, aryl substituted with a radical-COOR<4>; or R<2> is substituted C1-10alkyl, C2-10alkenyl or C3-7cycloalkyl; or R<2> is a radical of formula: (b-1); (b-2); -CpH2p-CH(OR<14>)-CqH2q-R<15> (b-3); -CH2-CH2-(O-CH2-CH2)m-OR<14> (b-4); -CH2-CH2-(O-CH2-CH2)m-NR<5a>R<5b> (b-5); -a<1>=a<2>-a<3>=a<4>- is -CH=CH-CH=CH- ; -N=CH-CH=CH- ;-CH=N-CH=CH- ; -CH=CH- N=CH- ; -CH=CH-CH=N- (c-5); wherein one of the hydrogen atoms in (c-1) - (c-5) is replaced by particular radicals; R<3> is nitro, cyano, amino, halo, hydroxy, C1-4alkyloxy, hydroxycarbonyl, substituted carbonyl, methanimidamidyl, mono- or di(C1-4alkyl)methanimidamidyl, N-hydroxy- methanimidamidyl or Het1. |
| priorityDate | 2004-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.